Association between atherogenic index of plasma and metabolic dysfunction-associated steatotic liver disease in Egyptian population: a case–control study
Alyrogenic index of plasma is independently and positively associated with MASLD, more degree of hepatic steatosis, insulin resistance and low adiponectin level, and using AIP alone or in combination with BMI could alarm clinicians to further investigate for presence of MASLD in individuals at outpatient clinics.
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) is hepatic steatosis concurrent with metabolic abnormalities like obesity, insulin resistance, dyslipidemia, and hypertension. We aimed to investigate the association of atherogenic index of plasma with metabolic dysfunction-associated steatotic liver disease (MASLD). The study included 156 MASLD subjects diagnosed by B-ultrasonography having ≥ one of cardiometabolic risk factors while excluding other liver diseases and 144 healthy controls. To all participants; lipid profile, liver enzymes, serum adiponectin and basal insulin level were measured. Calculation of BMI, AIP, LDL cholesterol, Homeostatic model assessment of insulin resistance (HOMA-IR), Fatty liver index (FLI) and Fibrosis-4 (FIB-4) score were done. Receiver operating characteristic curve was drawn to discriminate diagnostic performance of variables. In patients with MASLD, AIP was significantly correlated with increased age, HOMA-IR, FLI, decreased serum adiponectin, and low HDL-C. In multivariate analysis, after adjustment of BMI, LDL-C, HOMA-IR and serum adiponectin, AIP was associated with 3.67 more risk for MASLD (highest OR). To discriminate MASLD, the AUC for AIP was 0.719 (p < 0.001) at cut-off point of > 0.372, while AUC for Combination of AIP and BMI in total MASLD group was 0.865 and for overweight and obese patients was 0.937. Atherogenic index of plasma is independently and positively associated with MASLD, more degree of hepatic steatosis, insulin resistance and low adiponectin level. Using AIP alone or in combination with BMI could alarm clinicians to further investigate for presence of MASLD in individuals at outpatient clinics.
Among adults with hypertension in a Chinese single-center health check-up population, higher METS-IR was associated with a higher likelihood of prevalent MASLD and showed a graded, mildly non-linear pattern.
Feng Lu, L. Qiu, Peng Yu et al.· Frontiers in Endocrinology· 0 citations
Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-alcoholic fatty liver disease (NAFLD), is the hepatic presentation of metabolic syndrome. It shares the common pathophysiology of insulin resistance with type 2 diabetic mellitus (T2DM). The aim of this study was to est...
K. Kannangara, Wac Karunarathne, Nrp Perera et al.· Frontiers in Clinical Diabet...· 0 citations
Higher VAI values are associated with MASLD in patients with T1DM, however, waist circumference outperforms VAI in identifying MASLD, suggesting that VAI may serve as a complementary marker of metabolic dysfunction rather than a standalone screening tool for MASLD in this patient population.
A. Mantovani, I. Milani, R. Morandin et al.· Journal of Endocrinological...· 0 citations
BACKGROUND
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non- alcoholic fatty liver disease (NAFLD), is a prevalent liver condition characterized by excessive fat accumulation in hepatocytes, primarily due to metabolic risk factors. Steatosis, the initial accumulation of fat, can p...
Pragya Goswami, S. Ray, Abhishek Singhai et al.· Journal of the National Medi...· 0 citations
This review examines the clinical interpretation, biological context, and current limitations of the TyG index and its anthropometric and inflammatory derivatives in MASLD and recommends it be considered a metabolic risk marker rather than a stand-alone diagnostic test for MASLD or MASH.
Longzhou Chen, Yucai Tang, Hao Guo et al.· Frontiers in Medicine· 0 citations
Patients with T2DM, cardiovascular disease, and blood-based indices suggesting liver steatosis or fibrosis differed significantly with respect to the lipid profile, and an elevated HSI score, suggesting steatosis, was associated with dyslipidemia, and an elevated NFS score, suggesting fibrosis, was not.
Laura A. M. Konings, Weiwei Xu, Vivian D. de Jong et al.· Diabetology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.